Stoke is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.
BEDFORD, Mass.-- (BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company that is pioneering a new way to treat … A new type of medicine, STK-001, designed by Stoke Therapeutics increases healthy copies of the Nav1.1 sodium channel in pre-clinical animal and cell models.
the.
Stoke is seeking an enthusiastic and highly motivated Associate Director to join the Clinical Operations group.
Stoke Therapeutics is now enrolling for the MONARCH study to assess if this works as a treatment for patients with Dravet syndrome. Key Responsibilities Include: Join Stoke’s experienced and dedicated team to lead the development of transformative therapies for life threatening diseases. This is an opportunity to learn what it takes to support a busy biotechnology research lab from the standpoint of lab materials, including inventory management, purchasing and receiving.Stoke is seeking an enthusiastic and highly motivated Director/Senior Director, Quality Assurance to join the Quality group. See how our TANGO platform works.We are building a talented team to unite around a common goal – improving the lives of people with severe genetic diseases.
This position will also lead a multi-disciplinary, matrix team through highly complex decisions. This role will develop strong relationships, collaborate, and interact with various departments and levels of management at Stoke Therapeutics to accomplish the company’s objectives. This individual will also collaborate and develop strong relationships and partner with external collaborators to ensure the appropriate processes, systems, and activities are in place to protect the rights, safety, and welfare of study subjects. This position also offers the opportunity to apply Stoke’s platform to other serious diseases (including other neurologic diseases and ophthalmic diseases) and will take on a major leadership role in a rapidly growing organization. This individual interacts with and influences senior leadership in decision-making for the projects by setting strategic direction. This individual has the ultimate responsibility for development decisions assessing and integrating the input from various disciplines to create, maintain, and execute a global clinical development plan for each clinical program that will result in the regulatory approval of the compounds in multiple regions. This position reports to the Chief Medical Officer of the company.Stoke is seeking an enthusiastic and highly motivated Stoke is seeking an enthusiastic and highly motivated Site Services Associate to join the Facilities and Engineering Department.
Brief Summary: Stoke Therapeutics is evaluating the safety and tolerability of single ascending doses of STK-001 in patients with Dravet syndrome. future.
Consider joining us. The Senior Medical Director will lead and drive strategy for the company’s global genetic epilepsy clinical development portfolio, including Dravet syndrome, taking into consideration medical, scientific, regulatory and commercial aspects.
Stoke is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expressionLearn more about Stoke’s founders and their vision for helping people with severe genetic diseases caused by loss of function in a single gene.Our approach is designed to allow us to deliver disease-modifying therapies to a broad range of relevant tissues. We’re united around a common goal: to improve the lives of people living with severe genetic diseases.Stoke is always looking for individuals with a passion for developing precision medicines to tackle severe genetic diseases.This is an opportunity for a clinician at a fast-growing company focused on precision medicines for genetic diseases.
The successful candidate will be responsible for: helping to define, communicate and implement the company’s quality strategy and vision. proteins.
Preclinical data have shown our therapies to be highly precise, durable and controllable. This individual will have demonstrated a track record of success in his/her field, the capacity to lead with minimal supervision, plan strategically, achieve goals on time, and communicate effectively. At Stoke, we are building a team of talented scientists, experienced drug developers and insightful leaders to address severe genetic diseases.We are excited about breaking new scientific ground. STK-001 is an anti-sense oligonucleotide (ASO). Restoring. The successful candidate will be responsible for leading clinical trial (s) and a team to make key decisions related to the overall clinical trial execution strategy.